Editorial: E3 ubiquitin ligases: From structure to physiology to therapeutics, Volume II

Julien D F Licchesi; Heike Laman; Fumiyo Ikeda; Fleur M Ferguson; Victor M Bolanos-Garcia

doi:10.3389/fphys.2022.1038793

Editorial: E3 ubiquitin ligases: From structure to physiology to therapeutics, Volume II

Front Physiol. 2022 Sep 27:13:1038793. doi: 10.3389/fphys.2022.1038793. eCollection 2022.

Authors

Julien D F Licchesi¹, Heike Laman², Fumiyo Ikeda³, Fleur M Ferguson^{4

5}, Victor M Bolanos-Garcia⁶

Affiliations

¹ Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.
² Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
³ Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan.
⁴ Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, United States.
⁵ Department of Chemistry and Biochemistry, University of California San Diego, San Diego, CA, United States.
⁶ Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, England.

No abstract available

Keywords: Cancer; Dictyostelium discoideum; E3 ubiquitin ligases; SCF (Skp1-Cullin-F-box protein); cdc20; cullin-RING E3 ubiquitin ligase (CRL); ligase-substrate degron recognition; stress granule (SG).

Publication types

Editorial

Grants and funding

G-1701/PUK_/Parkinson's UK/United Kingdom